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Abstract
Background: Accidental hypothermia is a serious condition that requires immediate and accurate assessment to
determine severity and treatment. Currently, accidental hypothermia is evaluated using the Swiss grading system
which uses core body temperature and clinical findings; however, research has shown that core body temperature
is not associated with in-hospital mortality in urban settings. Therefore, we developed and validated a severity scale
for predicting in-hospital mortality among urban Japanese patients with accidental hypothermia.
Methods: Data for this multi-center retrospective cohort study were obtained from the J-point registry. We
included patients with accidental hypothermia who were admitted to an emergency department. The total cohort
was divided into a development cohort and validation cohort, based on the location of each institution. We
developed a logistic regression model for predicting in-hospital mortality using the development cohort and
assessed its internal validity using bootstrapping. The model was then subjected to external validation using the
validation cohorts.
Results: Among the 572 patients in the J-point registry, 532 were ultimately included and divided into the
development cohort (N = 288, six hospitals, in-hospital mortality 22.0%) and the validation cohort (N = 244, six
hospitals, in-hospital mortality 27.0%). The 5 “A” scoring system based on age, activities-of-daily-living status, near
arrest, acidemia, and serum albumin level was developed based on the variables’ coefficients in the development
cohort. In the validation cohort, the prediction performance was validated.
Conclusion: Our “5A” severity scoring system could accurately predict the risk of in-hospital mortality among
patients with accidental hypothermia.
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Background
Accidental hypothermia (AH) involves an unintentional de-
crease in core body temperature to ≤ 35 °C [1]. This condi-
tion is associated with high risks of hemodynamic collapse
and mortality (24–40%) [2–4], as the cooling heart results
in decreased cardiac output and electrical conduction ab-
normalities leading to life-threatening dysrhythmias, such
as bradycardic atrial fibrillation or ventricular fibrillation
[1]. Therefore, patients with AH must be immediately
assessed to determine their severity and select appropriate
advanced resuscitation and critical care techniques.
Although AH patients require immediate assessment of
the severity and critical care, there is no established risk as-
sessment tool specialized for AH patients. This might lead
to inappropriate decision-making due to a lack of accurate
information for the prognosis. The severity of AH is trad-
itionally evaluated using the Swiss grading system [1] which
is based on core body temperature and simple clinical find-
ings. However, other research has indicated that core body
temperature is not associated with in-hospital mortality in
urban settings [2, 4, 5]. Moreover, mortality is known to be
associated with various other factors, such as age, activities
of daily living (ADL), hemodynamic instability, hyperkale-
mia, and acidemia [1, 2, 4–9]. Unfortunately, it is difficult
to understand how these factors might influence mortality,
especially in an emergency setting. Thus, a simple and
user-friendly severity scale is needed to estimate mortality
after AH in urban settings. The present study aimed to de-
velop and validate a severity scaling system for predicting
in-hospital mortality using data from Japanese patients who
experienced AH in urban settings.
Methods
This multi-center retrospective cohort study complied
with the TRIPOD statement (Transparent Reporting of a
Multivariable Prediction Model for Individual Prognosis
or Diagnosis) regarding the reporting of the study’s
methods and results [10].
Data source
We obtained epidemiological and clinical information from
the J-point registry database which collects data from a net-
work of Japanese centers that treat patients with AH [2].
Eight centers are designated as Critical Care Medical Cen-
ters (CCMCs), and four sites are the emergency depart-
ments (EDs) of non-CCMC general hospitals in urban
areas of the Kyoto, Osaka, and Shiga prefectures in Japan.
Each year, the centers had a median of 19,651 ED visits
(interquartile range 13,281–27,554 visits). In Japan, CCMCs
are certified by the Ministry of Health, Labour and Welfare
based on EDs that treat patients for shock, trauma, resusci-
tation, and critical care which serve approximately 500,000
residents in each region; in these CCMCs, advanced treat-
ment like extracorporeal membrane oxygenation (ECMO)
is generally available [11]. The non-CCMC centers are pub-
lic or private general hospitals that cover a smaller regional
community, and, generally, advanced treatment such as
ECMO is unavailable.
The J-point registry includes patients who are retro-
spectively identified at each center using the International
Classification of Diseases, Tenth Revision (ICD-10) code
for hypothermia (T68). These patients were treated for
hypothermia between April 1, 2011, and March 31, 2016,
and had a body temperature of unknown or ≤ 35.0 °C. Pa-
tients were excluded from the registry if they or their fam-
ily members explicitly refused to be included in the
registry. Clinical data were extracted by emergency physi-
cians using a predefined data extraction sheet. The col-
lected data were re-checked by the J-Point Registry
Working Group members and either confirmed or
checked with the appropriate institution if there were con-
cerns regarding the data’s validity. Based on these factors,
572 patients were registered in the J-point registry. The
ethics committee of each center approved the registry
protocol and retrospective analysis of de-identified data.
Study population
The present study included adult patients (≥ 16 years old)
with a core body temperature of ≤ 35 °C at ED admission
and excluded patients with a non-AH core body
temperature (> 35 °C or unknown) and missing data regard-
ing age, sex, and mortality. The model was planned to
undergo both internal and external validation [12, 13].
Thus, a development cohort was created based on centers
from Kyoto city (four CCMCs and two non-CCMCs), while
the validation cohort was created based on centers from
Shiga and Osaka prefecture and Kyoto prefecture except
for Kyoto city (four CCMCs and two non-CCMCs). This
approach was selected because random sample splitting is
not recommended for relatively small cohorts (to avoid
over-fitting the data), which should instead be subdivided
based on a time period or geographical location [12, 14].
The validation cohort was considered sufficient for external
validation because the sample splitting was based on geo-
graphical location and not random allocation [12, 14].
Data collection and patient outcomes
The institutions were categorized as CCMC or
non-CCMC, and the annual number of ED visits,
the average number of hospital beds, and patients’
characteristics including sex, age, independent or
disturbed ADLs, and comorbidities were collected
(Additional file 1). The patients’ clinical characteris-
tics were defined as vital signs at hospital arrival
(core body temperature, systolic blood pressure
[SBP], and Glasgow [GCS] and Japan [JCS] Coma
Scales) and biological data (serum pH, potassium
[K+][mEq/L], and albumin [g/dL]). Details of the
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patients’ clinical characteristics are provided in Add-
itional file 1. Treatment characteristics were defined
as external and minimally invasive rewarming
methods (warm intravenous fluid, forced warm air,
warm blanket, and others) and active internal
rewarming (lavage, intravascular rewarming device,
and veno-venous and veno-arterial ECMO) (Add-
itional file 1: Table S1). The outcome of interest was
defined as in-hospital mortality, which was also de-
termined retrospectively.
Prognostic variable selection, data preparation, and
handling missing data
Based on previous studies and expert opinions, we se-
lected the admission values for age, ADL, body
temperature, level of consciousness, hemodynamic state,
serum pH, albumin, and K+ as potential predictor candi-
dates of in-hospital mortality [1, 2, 4–9]. To ensure that
the model is user-friendly, especially for emergency set-
tings, we categorized the potential covariates based on
their normal limit or commonly used ranges. Level of
Table 1 Patient and institution characteristics
Parameters Development cohort Validation cohort Total cohort
(N = 288) (N = 244) (N = 532)
Male, n (%) 144 (50.0%) 126 (51.6%) 270 (50.8%)
Age, years, median (IQR) 79 (69–87) 79 (64–87) 79 (67–87)
< 60, n (%) 37 (12.8%) 42 (19.3%) 79 (14.8%)
60–69 35 (12.2%) 37 (15.2%) 72 (13.5%)
70–79 76 (26.4%) 48 (19.7%) 124 (23.3%)
≥ 80 140 (48.6%) 117 (48.0%) 257 (48.3%)
Activities of daily living
Independent n (%) 190 (66.0%) 178 (73.0%) 368 (69.2%)
Disturbance 96 (33.3%) 66 (27.0%) 162 (30.5%)
Missing 2 (0.7%) 0 (0.0%) 2 (0.4%)
Comorbidities
Cardiovascular diseases, n (%) 126 (43.8%) 111 (45.5%) 237 (44.5%)
Neurological diseases 53 (18.4%) 40 (16.4%) 93 (17.5%)
Endocrine diseases 83 (28.8%) 47 (19.3%) 130 (24.4%)
Psychiatric diseases 55 (19.1%) 63 (25.8%) 118 (22.2%)
Malignant diseases 12 (4.2%) 4 (1.6%) 16 (3.0%)
Dementia 57 (19.8%) 51 (20.9%) 108 (20.3%)
Other 56 (19.4%) 38 (15.6%) 94 (17.7%)
External and minimally invasive rewarming
Warm intravenous fluid, n (%) 223 (77.4%) 168 (68.9%) 391 (73.5%)
Forced warm air 80 (27.8%) 4 (1.6%) 84 (15.8%)
Warm environment, blanket 242 (84.0%) 222 (91.0%) 464 (87.2%)
Other 23 (8.0%) 15 (6.1%) 38 (7.1%)
Active internal rewarming
Lavage, n (%) 29 (10.1%) 15 (6.1%) 44 (8.3%)
CHDF 4 (1.4%) 17 (7.0%) 21 (3.9%)
VV-ECMO 0 (0.0%) 2 (0.8%) 2 (0.4%)
VA-ECMO 3 (1.0%) 17 (7.0%) 20 (3.8%)
In-hospital mortality, n (%) 64 (22.2%) 66 (27.0%) 130 (24.4%)
Institution
CCMC, n (%) 4 (66.7%) 4 (66.7%) 8 (66.7%)
ED visit, median (IQR) 19,651 (12,076–28,439) 20,798 (12,319–28,801) 19,651 (13,252–27,811)
Number of beds, median (IQR) 640 (513–825) 374 (331–512) 510 (364–668)
IQR interquartile range, CHDF continuous hemodiafiltration, VV veno-venous, VA veno-arterial, ECMO extracorporeal membrane oxygenation, CCMC critical care
medical center, ED Visit annual number of emergency department visit
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consciousness was classified as mild (GCS 13–15 or JCS
0–3), moderate (GCS 9–12 or JCS 10–30), and severe
(GCS < 9 or JCS 100–300). Details of the JCS are de-
scribed in Additional file 1. A status of “near arrest” was
defined as an SBP of ≤ 60mmHg, unmeasurable values,
and cardiac arrest. In terms of missing values, variables
with < 3% missing data were analyzed based on complete
case analysis as such an analysis might then be feasible
[15]. If missing values were > 3%, missing data were cat-
egorized as “unknown,” because unmeasured values
might be informative in clinical settings (e.g., in minor
cases, blood gas analysis tends to be omitted). Tables 1
and 2 show the distributions of the covariate categories
for each cohort.
We did not calculate the required sample size, because
the J-point registry contains the largest number of AH
cases among the available literature, and we aimed to
empirically include all available data to maximize the
model’s power and generalizability [14]. There is a con-
sensus on the importance of having an adequate sample
size; however, there is no generally accepted approach
for estimating the required sample size when developing
and validating risk prediction models [14].
Development and evaluation of the prediction model
In the development cohort, predictors were selected
using a stepwise backward method based on the lowest
Akaike’s information criterion from the potential pre-
dictor candidates mentioned above. It allowed us to de-
velop a parsimonious predictor model for variable
retention, and multivariable logistic regression was sub-
sequently applied. Backward elimination is generally
Table 2 Vital sign and laboratory data on admission
Parameters Development cohort Validation cohort Total cohort
(N = 288) (N = 244) (N = 532)
Systolic blood pressure (mm Hg)
≧ 90, n (%) 212 (73.6%) 156 (63.9%) 368 (69.2%)
61–90 45 (15.6%) 45 (18.4%) 90 (16.9%)
Near cardiac arrest 31 (10.8 %) 43 (17.6%) 74 (13.9%)
Body temperature (°C), median (IQR) 30.7 (28.3–32.6) 31.0 (28–32.7) 30.8 (28.1–32.6)
35–32, n (%) 98 (34.0%) 77 (31.6%) 175 (32.9%)
32–28 124 (43.1%) 104 (42.6%) 228 (42.9%)
< 28 66 (22.9%) 63 (25.8%) 129 (24.2%)
Disturbance of consciousness
Mild, n (%) 110 (38.2%) 100 (41.0%) 210 (39.5%)
Moderate 90 (31.3%) 70 (28.7%) 160 (30.1%)
Severe 85 (29.5%) 68 (27.9%) 153 (28.8%)
Missing 3 (1.0%) 6 (2.5%) 9 (1.7%)
pH, median (IQR) 7.31 (7.25–7.37) 7.31 (7.21–7.37) 7.31 (7.23–7.37)
> 7.35, n (%) 85 (29.5%) 69 (28.3%) 154 (28.9%)
7.20–7.35 118 (41.0%) 98 (40.2%) 216 (40.6%)
< 7.20 42 (14.6%) 53 (21.7%) 95 (17.9%)
Missing 43 (14.9%) 24 (9.8%) 67 (12.6%)
K+ (mmol/l), median (IQR) 4.2 (3.6–4.7) 4.0 (3.5–4.6) 4.1 (3.6–4.7)
< 3.5, n (%) 59 (20.5%) 54 (22.1%) 113 (21.2%)
3.5–5.5 198 (68.8%) 155 (63.5%) 353 (66.4%)
> 5.5 30 (10.4%) 28 (11.5%) 58 (10.9%)
Missing 1 (0.3%) 7 (2.9%) 8 (1.5%)
Albumin (g/dl), median (IQR) 3.4 (2.9–4.0) 3.5 (2.9–4.0) 3.4 (2.9–4.0)
> 3 163 (56.6%) 142 (58.2%) 305 (57.3%)
≤ 3 77 (26.7%) 61 (25.0%) 138 (25.9%)
Missing 48 (16.7%) 41 (16.8%) 89 (16.7%)
In disturbance of consciousness, mild: Glasgow coma scale (GCS) 13–15, or Japan coma scale (JCS) 0–3, moderate: GCS 9–12, or JCS 10–30, severe: GCS < 9, or
JCS 100–300
IQR interquartile range, near arrest: systolic blood pressure ≤ 60 mmHg, unmeasurable, or cardiac arrest
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preferred as an automated selection procedure because
all correlations between the predictors are considered in
the modeling procedure [14]. Each variable’s coefficient β
and odds ratio were reported with the 95% confidence
interval (CI). The model’s performance was evaluated based
on Somers’ Dxy, the C index, the R
2 value, the calibration
intercept and slope, and the Brier score. Calibration plots
were also created to graphically depict the association be-
tween the predicted and observed in-hospital mortality
rates based on locally weighted scatterplot smoothing [13].
Internal validation involved a bootstrapping procedure
using 200 samples drawn with replacement from the ori-
ginal sample [13].
The fixed model was applied to the validation cohort for
external validation, and the discrimination and calibration
performances were compared to those from the develop-
ment cohort. Finally, we set the clinically useful simplified
risk stratification using a simple integer risk score based on
each variable’s coefficient β [13]. To assess discrimination
performance, we compared the c-index of our risk scoring
system with that of the core body temperature on admission,
which is categorized by the Swiss grading system, commonly
used to assess the severity in AH [1]. The diagnostic abilities
[sensitivity, specificity, positive likelihood ratio (LR+) and
negative likelihood ratio (LR−)] of each score were calcu-
lated. The calibration performance of risk stratification was
graphically evaluated in terms of the relationship between
the predicted and observed in-hospital mortality. All statis-
tical results were considered significant at two-sided P values
of < 0.05. Statistical analyses were performed using JMP Pro®
14 software (SAS Institute Inc., Cary, NC) and R software
(version 1.1.456; R Studio Inc.) with the “rms” package [15].
Results
Patient characteristics
Among the 572 patients in the J-point registry, we ex-
cluded 31 patients with a non-AH body temperature (>
35 °C or unknown), 8 non-adult patients (< 16 years old),
and 1 patient with missing data. Thus, 532 patients were
ultimately included, with an overall in-hospital mortality
of 24.4%. The patients were then divided into the devel-
opment cohort (N = 288, six hospitals [four CCMCs and
two non-CCMCs], in-hospital mortality 22.0%) and the
validation cohort (N = 244, six hospitals [four CCMCs
and two non-CCMCs], in-hospital mortality 27.0%)
(Fig. 1). The characteristics of the institutions and pa-
tients are shown in Tables 1 and 2, with the characteris-
tics and distributions being generally similar between
the cohorts. Missing values in pH and albumin were >
3% in each variable; thus, these missing values were cat-
egorized as “unknown,” and we conducted a complete
case analysis.
Performance and internal and external validation of the
model
The 5 “A” predictors (age, ADL, near arrest state, acide-
mia, and albumin) were selected. The variables’ coeffi-
cient β, adjusted odds ratio with 95% CI, and the
formula for predicted in-hospital mortality are shown in
the Additional file 1: Table S2 and Formula. Evaluation
of the model and the calibration plot in the development
and validation cohorts were shown in Additional file 1:
Table S3 and Figure S1 respectively, in Additional file 1.
The calibration plot in both cohorts revealed a relatively
good calibration, although the bias-corrected line re-
vealed slight overestimation of the mortality risk.
Risk scores and their performance
Based on the coefficient β of each predictor, a severity
scoring scale was created (Fig. 2, Additional file 1: Table
S4). The scoring system was based on age (60–69 years,
+ 1 point; 70–79 years, + 2 points; ≥ 80 years, + 3 points),
ADL status (disturbed, + 1 point), hemodynamic status
(near arrest, + 2 points), pH (7.35–7.2, + 1 point; < 7.2,
Fig. 1 Study flow chart
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+ 2 points), and serum albumin level (≤ 3 mg/dL, + 1
point). The c-index of our scoring system was 0.776 and
0.731 in the development and validation cohorts, re-
spectively. It was higher than that of the Swiss grading
system (0.731 vs 0.558) in the validation cohort with
statistical significance (Additional file 1: Table S5). The
severity scale for predicting in-hospital mortality was de-
fined as low risk (≤ 3 points), mild risk (4 points), mod-
erate risk (5 points), and severe risk (≥ 6 points) (Fig. 2).
In the validation cohort, the mean predicted mortality
and observed mortality in each group were 7.1% (95%
CI, 5.8–8.4%) and 12.6%, respectively, in the low-risk
group; 20.5% (95% CI, 18.7–22.3%) and 26.3%, respect-
ively, in the mild-risk group; 35.4% (95% CI, 33.3–37.6%)
and 42.5%, respectively, in the moderate-risk group; and
67.4% (95% CI, 65.1–69.6%) and 55.6%, respectively, in
the severe-risk group (Figs. 2 and 3). The diagnostic abil-
ities of in-hospital mortality prediction in the low-risk
group (≤ 3 points) were sensitivity 0.89 (95% CI, 0.82–
0.97) and LR − 0.33 (95% CI, 0.16–0.68), which were
suitable for rule-out, and in the severe-risk group (≥ 6
points), were specificity 0.91 (95% CI, 0.87–0.95) and LR
+ 3.37 (95% CI, 1.86–6.10), which were slightly suitable
for rule-in (Table 3). Graphical evaluation of the severity
scoring system revealed good calibration with the actual
results in the validation cohort and was the same as in
the development cohort (Fig. 3).
Discussion
The present study revealed that a “5A” severity scoring
scale (based on age, ADL, near arrest, acidemia, and al-
bumin) had better ability to predict mortality after AH
than the Swiss staging system based on the core body
temperature, with good discrimination and calibration
values based on internal and external validation. Fur-
thermore, the severity scoring system will help emer-
gency physicians to rapidly predict a patient’s prognosis
and make management decisions. To the best of our
knowledge, this is the first scale to be subjected to in-
ternal and external validation for predicting prognosis
among patients with AH in urban areas.
Previous literature and the present study’s strengths
Two reports have described methods for predicting prog-
nosis after cardiac arrest due to AH [16, 17]. The ICE sur-
vival score (based on sex, asphyxiation, and serum K+)
and the HOPE score (based on sex, asphyxia, age, K+, dur-
ation of cardiopulmonary resuscitation, and temperature)
could predict prognosis after treatment using extracorpor-
eal life support for AH cardiac arrest. However, these
scores were developed based on a literature review, which
included observational cohorts and case reports, and
might have been affected by publication bias and selection
bias. Moreover, these scores were not evaluated using
bootstrapping as internal validation or a separate dataset
for external validation which might have increased the risk
of overfitting; thus, it raises questions regarding the ap-
plicability of these scores to other populations.
In contrast, the present study has several strengths.
First, to our knowledge, ours is the largest cohort of pa-
tients with AH which allowed us to create two cohorts
based on geographical location and subject the model to
external validation. Second, we performed a bootstrap-
ping procedure to assess overfitting and over-optimism
during internal validation. Third, most patients were eld-
erly which agrees with a recent report that indicated that
most AH cases in Japan involve elderly people [2, 3, 9].
Population aging is a common public health issue in
Fig. 2 Calibration plot for each cohort. In the development cohort, the ideal dashed line reflects perfect calibration between the predicted and
observed mortality. The apparent performance, indicated by the dotted line, reflects the calibrated performance of the model. The solid line
reflects the bias-corrected performance based on bootstrapping. The validation cohort also has ideal dashed lines. The solid lines reflect the fitted
logistic calibration curve. The dotted lines reflect a smooth nonparametric fit using a locally weighted scatter plot for smoothing
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industrialized countries all over the world, and it is as-
sumed that most victims of AH in developed countries
will also be elderly. Most previous studies regarding AH
have focused on younger patients [6–8, 16–19], with
average ages of 35 years in the ICE score study and 36
years in the HOPE score study [16, 17]; therefore, these
scores are not applicable for the general population.
Thus, we believe that our model is more generalizable
for patients who experience AH in urban areas.
Interpretation
The present study evaluated clinically relevant variables
that can be summarized as the “5A”s (age, ADL, near ar-
rest, acidemia, and albumin). In this context, the patient’s
values for age, ADL, and serum albumin may reflect a vul-
nerable physiological status, and these variables are com-
monly used as prognostic factors in critical care [20–23].
Hemodynamic instability and pH are also important factors
in major critical care severity scoring scales [24] as they re-
flect the extent of vital organ hypoperfusion. Thus, we be-
lieve that the variables in our model could reflect
hypothermia-related physiological changes. Similar to other
studies [4], we did not incorporate body temperature as a
predictor, as we hypothesized that a hypothermia-related
decrease in organs’ oxygen consumption could protect
them despite the presence of hypoperfusion, which would
prevent body temperature from being strongly associated
with prognosis.
During the model’s development, we used bootstrapping
to account for slight over-optimism (e.g., correcting the C
statistic from 0.794 to 0.746). We also found overesti-
mation among the severe population in the bias-corrected
calibration plot which appears to be mainly related to the
small number of severe cases. The validation process also
revealed slight overestimation among the severe popula-
tion. Thus, we should interpret the findings carefully
among severe cases.
Clinical implications
We believe that this severity scoring scale allows clinicians
to rapidly assess the severity of AH patients, provide pa-
tients and their families with accurate information, and
improve their prognosis by more appropriately selecting
severe cases which require advanced resuscitation and
Fig. 3 Predicted and observed mortality based on the 5A scoring system. The median predicted mortality rate is shown for the quartile-based
sums of the risk scores in each cohort. The observed mortality rate reflected the proportion of in-hospital mortality. The predictions were well
calibrated with the observations. The 5A scoring system provided a simple and rapid prediction of post-accidental hypothermia prognosis. ADL
activities of daily living, SBP systolic blood pressure. Arrest was defined as SBP of ≤ 60 mmHg, unmeasurable values, and confirmed arrest
Table 3 Diagnostic ability of “5A” model for in-hospital mortality in validation cohort
Cutoff Specificity 95%CI Sensitivity 95%CI LR+ 95%CI LR− 95%CI
8 0.99 (0.97–1.00) 0.09 (0.02–0.16) NA NA NA NA
7 0.98 (0.96–1.00) 0.21 (0.11–0.31) 9.44 (3.22–27.65) 0.81 (0.71–0.92)
6 0.91 (0.87–0.95) 0.30 (0.19–0.41) 3.37 (1.86–6.10) 0.77 (0.65–0.90)
5 0.78 (0.72–0.84) 0.56 (0.44–0.68) 2.56 (1.80–3.63) 0.56 (0.42–0.75)
4 0.54 (0.47–0.62) 0.79 (0.69–0.89) 1.73 (1.41–2.12) 0.39 (0.24–0.63)
3 0.33 (0.26–0.39) 0.89 (0.82–0.97) 1.33 (1.16–1.51) 0.33 (0.16–0.68)
2 0.16 (0.10–0.21) 0.97 (0.93–1.0) 1.15 (1.07–1.24) 0.19 (0.05–0.79)
1 0.06 (0.02–0.09) 0.98 (0.96–1.0) NA NA NA NA
Sp specificity, Se sensitivity, LR+ positive likelihood ratio, LR− negative likelihood ratio, CI confidence interval
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critical care. In outdoor activity (e.g., skiing, climbing) asso-
ciated settings, most AH patients are healthy young ath-
letes. In such situations, even if the probability of death is
over 60%, aggressive treatment by physicians is reasonable.
On the other hand, in urban areas, most AH patients are
elderly [3, 9]. Since there is no established risk assessment
tool available for their treatment, we are apprehensive
about the appropriate treatment, because enough informa-
tion for the prognosis is not available. For instance, elderly
patients with impending death might be treated too inva-
sively, without discussing the prognosis with their relatives,
or those with good survival prospects might undergo early
withdrawal of the treatment. The severity scoring system
based on easily accessible data (“5A”) enables easy progno-
sis assessment by physicians. Aggressive treatment might
be reasonable for patients found to be in the low-risk group
(≤ 3 points), even if they are elderly. Physicians can easily
identify the condition requiring critical care for those in the
severe-risk group (≥ 6 points), and based on the possibility
of prognosis, they can decide the indication after discussing
with the patient’s relatives. Therefore, our risk scoring sys-
tem can lead to rational decision-making based on the
probability of prognosis evidence.
Limitations
This study has several limitations. First, despite the
generalizability of our model to similar urban areas, it is
unclear if this model can be applied to other settings, for
instance, an outdoor activity (i.e., skiing, mountain
climbing, etc.) associated setting, in which most patients
are healthy young athletes. Since our model was devel-
oped from an urban population, in which treatment is
focused on elderly people who stay indoors [2, 9], the
population and characteristics between these settings are
totally different. A second limitation is the relatively
small sample size which could have increased the risk of
overfitting and optimism [14]. A third limitation is the
absence of complete detailed data in the J-point registry
regarding the AH event, the clinical course after admis-
sion, treatment, the neurological outcome, and the cause
of death. Fourth, we did not compare the usefulness or
diagnostic ability with general risk assessment tool for
critically ill patients such as SOFA or APACHE2. There-
fore, further research is needed to determine the validity,
generalizability, and clinical usefulness of our model in
other cohorts and to evaluate its clinical utility.
Conclusion
The present study revealed that the 5A severity scale
had good discrimination and calibration for predicting
in-hospital mortality after AH based on internal and ex-
ternal validation. We believe that this severity scoring
scale can be useful to rapidly assess the severity of pa-
tients with AH.
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